Medical care expenditures and earnings losses among persons with arthritis and other rheumatic conditions in 2003, and comparisons with 1997.

OBJECTIVE To obtain estimates of medical care expenditures and earnings losses associated with arthritis and other rheumatic conditions and the increment in such costs attributable to arthritis and other rheumatic conditions in the US in 2003, and to compare these estimates with those from 1997. METHODS Estimates for 2003 were derived from the Medical Expenditures Panel Survey (MEPS), a national probability sample of households. We tabulated medical care expenditures of adult MEPS respondents, stratified by arthritis and comorbidity status, and used regression techniques to estimate the increment of medical care expenditures attributable to arthritis and other rheumatic conditions. We also estimated the earnings losses sustained by working-age adults with arthritis and other rheumatic conditions. Estimates for 2003 were compared with those from 1997, inflated to 2003 terms. RESULTS In 2003, there were 46.1 million adults with arthritis and other rheumatic conditions (versus 36.8 million in 1997). Adults with arthritis and other rheumatic conditions incurred mean medical care expenditures of $6,978 in 2003 (versus $6,346 in 1997), of which $1,635 was for prescriptions ($899 in 1997). Expenditures for adults with arthritis and other rheumatic conditions totaled $321.8 billion in 2003 ($233.5 billion in 1997). In 2003, the mean increment in medical care expenditures attributable to arthritis and other rheumatic conditions was $1,752 ($1,762 in 1997), for a total of $80.8 billion ($64.8 billion in 1997). Persons with arthritis and other rheumatic conditions ages 18-64 years earned $3,613 less than other persons (versus $4,551 in 1997), for a total of $108.0 billion (versus $99.0 billion). Of this amount, $1,590 was attributable to arthritis and other rheumatic conditions (versus $1,946 in 1997), for a total of $47.0 billion ($43.3 billion in 1997). CONCLUSION Our findings indicate that the increase in medical care expenditures and earnings losses between 1997 and 2003 is due more to an increase in the number of persons with arthritis and other rheumatic conditions than to costs per case.

[1]  E. Yelin,et al.  Labor force participation among persons with musculoskeletal conditions, 1970-1987. National estimates derived from a series of cross-sections. , 2010, Arthritis and rheumatism.

[2]  N. Duan.  Smearing Estimate: A Nonparametric Retransformation Method , 1983 .

[3]  L. Trupin,et al.  A national study of medical care expenditures for musculoskeletal conditions: the impact of health insurance and managed care. , 2001, Arthritis and rheumatism.

[4]  C. Helmick,et al.  Cost-effectiveness of the arthritis self-help course. , 1998, Archives of internal medicine.

[5]  F. Breedveld,et al.  Osteoarthritis--the impact of a serious disease. , 2004, Rheumatology.

[6]  D. Rice,et al.  The economic cost of illness revisited. , 1976, Social security bulletin.

[7]  J. Reginster,et al.  The prevalence and burden of arthritis. , 2002, Rheumatology.

[8]  E. Badley.  The economic burden of musculoskeletal disorders in Canada is similar to that for cancer, and may be higher. , 1995, The Journal of rheumatology.

[9]  L. Trupin,et al.  Medical care expenditures and earnings losses of persons with arthritis and other rheumatic conditions in the United States in 1997: total and incremental estimates. , 2004, Arthritis and rheumatism.

[10]  F. Guillemin,et al.  Cost of illness studies in rheumatic diseases. , 2002, Current opinion in rheumatology.

[11]  A. Rat,et al.  Rheumatoid arthritis: direct and indirect costs. , 2004, Joint, bone, spine : revue du rhumatisme.

[12]  P. Brooks.  The burden of musculoskeletal disease—a global perspective , 2006, Clinical Rheumatology.

[13]  Hyon K. Choi,et al.  Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patients. , 2003, Arthritis and rheumatism.

[14]  H. Kautiainen,et al.  The costs of early inflammatory joint disease: a population‐based study in southern Sweden , 2003, Scandinavian journal of rheumatology.

[15]  E. Yelin,et al.  The development of depressive symptoms among women with rheumatoid arthritis. The role of function. , 1995, Arthritis and rheumatism.

[16]  H. Harwood,et al.  Economic costs of alcohol abuse and alcoholism. , 1998, Recent developments in alcoholism : an official publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism.

[17]  C. Morris,et al.  A Comparison of Alternative Models for the Demand for Medical Care , 1983 .

[18]  N. Cooper.  Economic burden of rheumatoid arthritis: a systematic review. , 2000, Rheumatology.

[19]  Rowland W Chang,et al.  The costs of arthritis. , 2003, Arthritis and rheumatism.

[20]  Rice Dp,et al.  Estimating the cost of illness. , 1967 .

[21]  C. Helmick,et al.  Projections of US prevalence of arthritis and associated activity limitations. , 2006, Arthritis and rheumatism.

[22]  D. Commerce.  Statistical abstract of the United States , 1978 .

[23]  L. March,et al.  Economics of osteoarthritis: a global perspective. , 1997, Bailliere's clinical rheumatology.

[24]  A. Woolf,et al.  Burden of major musculoskeletal conditions. , 2003, Bulletin of the World Health Organization.

[25]  J. Sommers.  Some Relationships and Possible Models for State Estimates from the Medical Expenditure Panel Survey, Household Component , 2006 .

[26]  Dorothy P. Rice,et al.  The economic costs of illness: A replication and update , 1985, Health care financing review.

[27]  L. March,et al.  10 Economics of osteoarthritis: a global perspective , 1997 .

[28]  G. Hawker,et al.  The economic burden of disabling hip and knee osteoarthritis (OA) from the perspective of individuals living with this condition. , 2005, Rheumatology.

[29]  K. Hieke,et al.  The costs of rheumatoid arthritis: an international long-term view. , 2000, Seminars in arthritis and rheumatism.

[30]  Badley Em.  The economic burden of musculoskeletal disorders in Canada is similar to that for cancer, and may be higher. , 1995 .

[31]  P. Brooks.  Impact of osteoarthritis on individuals and society: how much disability? Social consequences and health economic implications. , 2002, Current opinion in rheumatology.

[32]  M. Minor.  2002 Exercise and Physical Activity Conference, St Louis, Missouri: exercise and arthritis "we know a little bit about a lot of things em leader ". , 2003, Arthritis and rheumatism.

[33]  D. Redelmeier,et al.  Assessing the clinical importance of symptomatic improvements. An illustration in rheumatology. , 1993, Archives of internal medicine.

[34]  Cohen Sb,et al.  Estimation procedures in the 1996 Medical Expenditure Panel Survey Household Component. , 1999 .